Medirom Healthcare Technologies Stock Analysis

Medirom Stock Analysis Notes

About 40.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.05. Medirom Healthcare had not issued any dividends in recent years. MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan. MEDIROM Healthcare operates under Personal Services classification in the United States and is traded on NASDAQ Exchange. It employs 171 people. To find out more about Medirom Healthcare Technologies contact Jacques Blanchard at 81 3 6721 7364 or learn more at https://medirom.co.jp.

Medirom Healthcare Investment Alerts

Medirom Healthcare Upcoming and Recent Events

Medirom Healthcare Thematic Classifications

Medirom Stock Institutional Investors

Note, although Medirom Healthcare's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Medirom Market Capitalization

The company currently falls under 'Micro-Cap' category with a total capitalization of 29.59 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medirom Healthcare's market, we take the total number of its shares issued and multiply it by Medirom Healthcare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Medirom Profitablity

Management Efficiency

At this time, Medirom Healthcare's Return On Tangible Assets are very stable compared to the past year. As of the 24th of April 2024, Return On Capital Employed is likely to grow to 0.07, though Return On Equity is likely to grow to (2.14). At this time, Medirom Healthcare's Intangible Assets are very stable compared to the past year. As of the 24th of April 2024, Return On Tangible Assets is likely to grow to 0.03, though Net Tangible Assets are likely to grow to (1 B). Medirom Healthcare's management efficiency ratios could be used to measure how well Medirom Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 24th of April, Medirom Healthcare secures the Mean Deviation of 0.7697, risk adjusted performance of 0.0039, and Standard Deviation of 1.24. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medirom Healthcare, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Medirom Healthcare, which can be compared to its peers in the industry. Please verify Medirom Healthcare mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and kurtosis to decide if Medirom Healthcare Technologies is priced some-what accurately, providing market reflects its recent price of 5.99 per share. Given that Medirom Healthcare has information ratio of (0.07), we recommend you to check Medirom Healthcare's last-minute market performance to make sure the company can sustain itself at a future point.

Medirom Healthcare Price Movement Analysis

Medirom Healthcare Predictive Daily Indicators

Medirom Healthcare Corporate Filings

Medirom Healthcare Forecast Models

Medirom Healthcare's time-series forecasting models are one of many Medirom Healthcare's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Medirom Healthcare's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Medirom Healthcare prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Medirom shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Medirom Healthcare. By using and applying Medirom Stock analysis, traders can create a robust methodology for identifying Medirom entry and exit points for their positions.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

When running Medirom Healthcare's price analysis, check to measure Medirom Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medirom Healthcare is operating at the current time. Most of Medirom Healthcare's value examination focuses on studying past and present price action to predict the probability of Medirom Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medirom Healthcare's price. Additionally, you may evaluate how the addition of Medirom Healthcare to your portfolios can decrease your overall portfolio volatility.

Is Medirom Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.